ArticleJournal of the American Chemical Society2025
Vanadium-Mediated Carbon Isotope Exchange of Terminal Alkenes.
Article in Journal of the American Chemical Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Toward vanadium-mediated alkyne metathesis.Chemical science · 2026Article
- An IntegratedACS catalysis · 2026Article
- Evaluation of Steric and Electronic Parameters of NHCs on Vanadium Imido Alkylidenes for Olefin Metathesis.ACS catalysis · 2025Article
- Silica-Supported Vanadium-oxo-alkylidene for Self-Metathesis of Propene.Journal of the American Chemical Society · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The incorporation of carbon isotopes into bioactive compounds is of great importance in chemistry, biology, and medicine. Especially valuable are catalytic procedures that rely on a limited collection of available labeled materials. Recently we introduced a conceptually novel solution to carbon isotope exchange (CIE) for terminal olefins based on the preference of V alkylidenes for degenerate metathesis. However, the previous report utilized a V catalyst that suffered from functional group tolerance due to the high electrophilicity of the V center, making it impractical for biological compounds. Herein, we utilized V catalysts containing electron-donating groups to overcome those challenges. We utilize isotopically labeled substituted styrene as a labeled ═
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.